Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Glioblastoma multiforme: Metabolic differences to peritumoral tissue and IDH-mutated gliomas revealed by mass spectrometry imaging.

Neuropathology : official journal of the Japanese Society of Neuropathology - 1 Dec 2020

Kampa Judith M, Kellner Udo, Marsching Christian, Ramallo Guevara Carina, Knappe Ulrich J, Sahin Mikail, Giampà Marco, Niehaus Karsten, Bednarz Hanna

Abstract excerpt

Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor. High infiltration rates and poor therapy responses make it the deadliest glioma. The tumor metabolism is known to differ from normal one and is influenced through various factors which can lead to longer survival. Metabolites are small molecules (< 1500 Da) that display the metabolic pathways in the tissue. To determine the metabolic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioblastoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Source

Identifiers

PMID: 32662157
DOI: 10.1111/neup.12671

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Glioblastoma multiforme: Metabolic differences to peritumoral tissue and IDH-mutated gliomas revealed by mass spectrometry imaging.PMID 32662157Read ↗

Metabolomic profiles of human glioma inform patient survivalSemantic proximity Read ↗

Metabolomic Profiles of Human Glioma Inform Patient Survival.Semantic proximity Read ↗

Methodological Approaches for Assessing Metabolomic Changes in Glioblastomas.Semantic proximity Read ↗

A map of the altered glioma metabolism.Semantic proximity Read ↗

Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment.Semantic proximity Read ↗

Magnetic resonance spectroscopy of isocitrate dehydrogenase mutated gliomas: current knowledge on the neurochemical profile.Semantic proximity Read ↗

Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.Semantic proximity Read ↗

Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma.Semantic proximity Read ↗

Intraoperative detection of isocitrate dehydrogenase mutations in human gliomas using a miniature mass spectrometer.Semantic proximity Read ↗

Absolute quantification of 2-hydroxyglutarate on tissue by matrix-assisted laser desorption/ionization mass spectrometry imaging for rapid and precise identification of isocitrate dehydrogenase mutations in human glioma.Semantic proximity Read ↗

The genomic alterations in glioblastoma influence the levels of CSF metabolites.Semantic proximity Read ↗

Advancing glioblastoma treatment by targeting metabolismSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.